CASP3 and liver cancer: There is evidence of apoptosis via the mitochondrial pathway, such as mitochondrial fragmentation and the activation of caspases 3/7 and 9 with up to a six-fold increase when liver cancer cells (HEPG2) were treated with PS2Aa1a at a concentration of 2 μg/mL for 24 h [10].